How Avelumab Can Help Patients With Locally Advanced or Metastatic Bladder Cancer With Dr. Tom Powles


Read the episode’s transcript

In Episode 53 of Bladder Cancer Matters, host Rick Bangs talks with Dr. Tom Powles about an interesting clinical trial he and others conducted studying the effectiveness of a drug to treat metastatic bladder cancer. Among other topics, they discuss:

Dr. Tom Powles of Bart’s Cancer Center at St. Bartholomew Hospital in London
  • The JAVELIN 100 trial that successfully studied the effectiveness of avelumab after chemotherapy in bladder cancer patients who have locally advanced metastatic disease
  • What avelumab is and how it is used
  • The questions that Dr. Powles hoped would be answered by the JAVELIN 100 trial
  • How those conducting the trial assessed the quality of life of the patients receiving avelumab
  • The role that wearable technology like a smartwatch can play in measuring patients’ quality of life and health

Never miss an episode of Bladder Cancer Matters by subscribing in your favorite podcasting platform like those below.